Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide
Benedetta Rambaldi(Harvard University), Rizwan Romee(Washington University in St. Louis), Sharmila Chamling(Harvard University), Corey Cutler(Harvard University), John Koreth(Otsuka (Japan)), Vincent T. Ho(Dana-Farber Cancer Institute), Leutz Buon(Harvard University), Mahasweta Gooptu(Harvard University), Haesook T. Kim(Dana-Farber Cancer Institute), Catherine J. Wu(Dana-Farber Cancer Institute), Yohei Arihara(Sapporo Medical University), Joseph H. Antin(Dana-Farber Cancer Institute), Robert J. Soiffer(Dana-Farber Cancer Institute), Edwin P. Alyea(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Tomohiro Kubo(Sapporo Medical University), Sarah Nikiforow(Otsuka (Japan)), Carol Reynolds(Harvard University), Jerome Ritz(Dana-Farber Cancer Institute)
Cited by 109
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Towards personalized, tumour-specific, therapeutic vaccines for cancer
|Nature reviews. Immunology|2017|1k
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
|Nature Medicine|2020|1k
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
|Science Translational Medicine|2016|916